Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells.
Jin-Kwan LeeSeo-Young KooHye-Mi NamJee-Boong LeeJiwon KoKyung-Mo KimEun-Ji ParkTae Jin KimHo LeeHeounjeong GoChang-Woo LeePublished in: Cellular & molecular immunology (2021)
The homeostatic balance between effector T cells and regulatory T cells (Tregs) is crucial for adaptive immunity; however, epigenetic programs that inhibit phosphorylation to regulate Treg development, peripheral expression, and suppressive activity are elusive. Here, we found that the Ssu72 phosphatase is activated by various T-cell receptor signaling pathways, including the T-cell receptor and IL-2R pathways, and localizes at the cell membrane. Deletion of Ssu72 in T cells disrupts CD4+ T-cell differentiation into Tregs in the periphery via the production of high levels of the effector cytokines IL-2 and IFNγ, which induce CD4+ T-cell activation and differentiation into effector cell lineages. We also found a close correlation between downregulation of Ssu72 and severe defects in mucosal tolerance in patients. Interestingly, Ssu72 forms a complex with PLCγ1, which is an essential effector molecule for T-cell receptor signaling as well as Treg development and function. Ssu72 deficiency impairs PLCγ1 downstream signaling and results in failure of Foxp3 induction. Thus, our studies show that the Ssu72-mediated cytokine response coordinates the differentiation and function of Treg cells in the periphery.
Keyphrases
- regulatory t cells
- dendritic cells
- signaling pathway
- end stage renal disease
- induced apoptosis
- newly diagnosed
- ejection fraction
- immune response
- binding protein
- poor prognosis
- chronic kidney disease
- dna methylation
- cell proliferation
- prognostic factors
- drug delivery
- cancer therapy
- public health
- cell cycle arrest
- protein kinase